RVNC
Revance Therapeutics, Inc
Revance Therapeutics, Inc 13F Holders
RVNC Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $3.03
1 value investing guru has made changes to the Revance Therapeutics, Inc (RVNC) position according to the gurus' 2025 Q1 SEC quarterly report(s). RVNC has been completely sold out by 1 guru(s)
Which gurus or hedge funds bought RVNC in 2025 Q1?
According to the 2025 Q1 SEC filing(s) Revance Therapeutics, Inc (RVNC) has not been purchased by any super investor.
To see more about who is investing in Revance Therapeutics, Inc (RVNC), please go to the RVNC ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.